New research suggests popular GLP-1 weight loss drugs like Ozempic, Wegovy, and Mounjaro may raise the risk of osteoporosis and gout. A large five-year study found slightly higher rates of bone density issues and gout among users, prompting doctors to urge monitoring, balanced nutrition, and medical supervision during treatment.